February 2017

Recently, the Food and Drug Administration (FDA) finalized guidance detailing its approach to assigning non-proprietary names to…

The United States Department of Health and Human Services (HHS) Office of Inspector General (OIG) recently published a report,…

We have taken an interest in the growing biosimilars market in the United States. Recently, we covered the Friends of Cancer…

As reported by Regulatory Focus, the FDA announced the “safety labeling changes” (SLC) program. It will be reportedly…

An article in the Philadelphia Business Journal published in early January 2017 focused on Open Payments and payment…

On February 3, 2017, the Department of Justice (DOJ) announced that False Claims Act (FCA) penalties will once again be…

During the last weeks of the Obama Administration, CMS continued to roll out new mandatory bundled payments models. Rep. Tom Price…

Walgreen Co. (“Walgreens”) has agreed to pay $50 million to settle allegations that it gave kickbacks to government health care…

Medical device maker Zimmer Biomet Holdings, Inc., agreed to pay $30.5 million to resolve Department of Justice (DOJ) and…

The Centers for Medicare and Medicaid Services (CMS finalized) the 2017 Medicare Physician Fee Schedule (PFS) rule. This rule,…